Humanscape hosts ‘3 day Masterclass in Orphan Drugs’

HUM | 08.05| 586

Humanscape hosts ‘3 day Masterclass in Orphan Drugs’ on Sep 24th-26th.

The instuctor for this master class is David Schwicker, former vise president of global CRO ‘PAREXEL’. He will be giving lectures on various important topics concerning new drug development for rare, incurable diseases, including

  • Orphan designation application and maintenance
  • OMP Regulatory, Legislative, and “Fast to Market” Strategies
  • Orphan Markets, The Present and Future Landscape

and following workshops — this curriculum is same as to the ones given to other global big pharms, such as AstraZeneca, Pfizer, Merck, GSK, Sanofi.

Through the lecture, Humanscape expects to not only build further expertise in new drug development for rare disease but share our vision with experts in related fields who would be participating this class.

  • Date: 2019.09.24–26, full 3 days
  • Venue: Google for Start-ups (417, Yeongdong-daero, Gangnam-gu, Seoul)
  • Sign-up:
  • Details:
  • Instructor David Schwicker
    -Founder of ORPHA Strategy Consulting
    -Former Vice President of PAREXEL
    -Founder of Phase IV Programs LLC
    -Co-Founder of Outcomes International, Basel
    -Former Managing Director at Abt Bio-Pharma Solutions Europe

Get to know us better!
Join our official channels below.

Telegram(EN) :
KakaoTalk(KR) :
Website :
Medium :
Facebook :
Twitter :
Reddit :
Bitcointalk announcement :
Email :

Humanscape hosts ‘3 day Masterclass in Orphan Drugs’ was originally published in Humanscape on Medium, where people are continuing the conversation by highlighting and responding to this story.

Comment 0


Are you sure you want to delete this post?